THE ORIGINAL CONVENIENT PREFILLED, NO-MIX SYRINGE FOR GnRH TREATMENT OF ADVANCED PROSTATE CANCER IN ADULTS
CAMCEVI® is still the first and only sub-Q leuprolide therapy in a prefilled, no-mix, ready-to-inject formulation that simplifies GnRH agonist preparation—offering consistent testosterone suppression, after the initial injection, to castrate levels from Week 4 to Week 48.1
Don’t sweat syringe prep1Don’t SweatThe Schedule
Keep patients on schedule. Simply click or tap the dosage dial and rotate to schedule your patient’s next treatment date.*
*Recommended Dosage: 42 mg subcutaneously every 6 months.
PROVEN
LEUPROLIDE EFFICACY
CAMCEVI offers proven leuprolide efficacy in a convenient prefilled, no-mix syringe.1
SIMPLIFIED
PREPARATION
CAMCEVI comes prefilled with no mixing required—simplifying syringe prep for you.1
DON’T SWEAT
THE J CODE
Permanent J Code J1952 is unique to CAMCEVI and unaffected by market price changes.
Don’t sweat
the coverage2,3
*As of 02/01/24.
Coverage is not indicative of
utilization management criteria.
96%
patients covered by
Medicare*
91%
patients covered by
Commercial*
*As of 02/01/24.
Coverage is not indicative of
utilization management criteria.
Real stories from real people
Watch healthcare professionals talk about their experiences with CAMCEVI.*
NURSE
Sarah L.
“Our patients have stayed at castration
level so we have not had to switch a
patient off of CAMCEVI.”
View more CAMCEVI testimonials.
*As with all medications, individual patient experiences may vary.
LIVES AND GROWING*
Patients who have undergone treatment on CAMCEVI4
*As of 02/29/2024.
